Doxacurium

Director, 8, Tongue Tie

Director, 5, Tongue Tie

Director, 5, Tongue Tie

Director, 4, Tongue Tie

A potent, reversible inhibitor of AMPK (Ki = 109 nM) dose-dependently inhibits the bone morphogenetic protein type 1 receptors ACTR-I (ALK2), BMPR-IA (ALK3), and BMPR-IB (ALK6) downregulates the Akt/mTOR pathway to induce autophagy in U251 human

A potent, reversible inhibitor of AMPK (Ki = 109 nM) dose-dependently inhibits the bone morphogenetic protein type 1 receptors ACTR-I (ALK2), BMPR-IA (ALK3), and BMPR-IB (ALK6) downregulates the Akt/mTOR pathway to induce autophagy in U251 human

A metabolic precursor of dopamine that crosses the blood brain barrier used to treat Parkinson&rsquos disease and stroke damage.

Homocarnosine TFA is a dipeptide of γ-aminobutyric acid (GABA) and histidine unique to brain. Homocarnosine TFA is an inhibitory neuromodulator synthesized in the neuron from GABA and exhibiting anticonvulsant effects. Homocarnosine TFA has

Homocarnosine TFA is a dipeptide of γ-aminobutyric acid (GABA) and histidine unique to brain. Homocarnosine TFA is an inhibitory neuromodulator synthesized in the neuron from GABA and exhibiting anticonvulsant effects. Homocarnosine TFA has

Homocarnosine TFA is a dipeptide of γ-aminobutyric acid (GABA) and histidine unique to brain. Homocarnosine TFA is an inhibitory neuromodulator synthesized in the neuron from GABA and exhibiting anticonvulsant effects. Homocarnosine TFA has

Homocarnosine TFA is a dipeptide of γ-aminobutyric acid (GABA) and histidine unique to brain. Homocarnosine TFA is an inhibitory neuromodulator synthesized in the neuron from GABA and exhibiting anticonvulsant effects. Homocarnosine TFA has

Dynorphin A (1-10) (TFA), an endogenous opioid neuropeptide, binds to extracellular loop 2 of the κ-opioid receptor . Dynorphin A (1-10) (TFA) also blocks NMDA -activated current with an IC 50 of 42.0 μM.Appearance:SolidIC50&amp: Target:NMDA